Experience of the Use of Trabectedin (ET-743, Yondelis™) in 21 Patients with Pre-treated Advanced Sarcoma from a Single Centre

The disease responses and durable nature of disease stabilisation seen in a proportion of our patients support the continued investigational use of this drug in the treatment of advanced soft tissue sarcomas.